Cancer Diagnostics Market Size to Reach USD 268.10 Billion in 2028: CAGR of 6.3% | Reports and Data

NEW YORK, Aug. 16, 2021 /PRNewswire/ -- The global cancer diagnostics market size is expected to reach USD 268.10 Billion in 2028 and register a CAGR of 6.3%, according to the latest report by Reports and Data. Major factors such as increasing demand for cancer diagnostics tests due to easy availability and effectiveness, rising incidence of breast cancer, and initiatives by government and private organizations to create awareness about cancer are driving global market revenue growth. 

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3707

Cancer is a one of the leading cause of death across the globe. In 2020 alone, around 10 million deaths were reported by World Health Organization. Excess consumption of alcohol, tobacco, unhealthy lifestyle, lack of physical fitness, and other associated diseases like diabetes could lead to various cancer types. Cancer mortality can reduce if detected early. Thus, early detection, screening, and accurate cancer diagnosis are of utmost importance. Cancer diagnostics is one such method that helps to identify different proteins and biomarkers that could help in suspecting presence of cancer. Some of the widely used cancer diagnostics tests are imaging, laboratory tests, genetic tests, biopsy, and endoscopy. Factors such as rising prevalence of breast cancer, ovarian cancer, and lung cancer worldwide, rising geriatric population and increasing healthcare expenditure, improvements in healthcare sector, and increasing demand for effective screening tests are supporting global market revenue growth. In addition, rise in funds for research and development activities and increasing focus of market players to develop more affordable and advanced diagnostics tests and kits is expected to boost market growth going ahead. 

However, factors such as high initial investment, high adoption of refurbished diagnostic systems, and risks associated with high radiation exposure are expected to hamper growth of cancer diagnostics market to a certain extent during the forecast period. 

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/cancer-diagnostics-market

Some key highlights in the report:

• Based on test type, the imaging segment is expected to register rapid revenue growth between 2021 and 2028. Increasing prevalence of types of cancer, rising healthcare and diagnostic expenditure, high demand for advanced imaging tests such as Magnetic Resonance Imaging (MRI) mammography, Computed Tomography (CT) scan for quick and pain-free primary diagnosis and rising investments to develop more enhanced imaging test are boosting segment revenue growth.
• Among the application segments, the breast cancer segment is expected to account for significantly larger revenue share over the forecast period. Breast cancer is one of the most commonly caused cancers across the globe. Factors such as increasing awareness programs, initiatives by government and private firms to promote breast cancer awareness, and increasing investments to launch new detection products are fueling segment growth.
• The cancer diagnostics market in North America is expected to account for largest revenue share between 2021 and 2028 owing to factors such as high awareness about early detection and cancer diagnosis, rising prevalence of types of cancer, high investments in R&D activities, availability of advanced cancer diagnostic tests, and presence of skilled healthcare professionals.
• Asia Pacific is expected to register rapid revenue growth over the forecast period. Factors such as high prevalence of cancer, improving healthcare infrastructure, rising disposable income, increasing awareness about early cancer diagnosis, and favorable government initiatives are boosting market growth in Asia Pacific.

Key players operating in the global cancer diagnostics market include:

• Thermo Fischer Scientific
• GE Healthcare
• Abbott Laboratories
• Hologic Inc.
• Agilent Technologies Inc.
• Roche Diagnostics
• FUJIFILM Corporation
• Danaher Corporation
• DiaSorin
• Myriad Genetics Inc.
• Siemens Healthineers AG
• bioMérieux SA
• Bio-Rad Laboratories
• Cancer Diagnostics Inc.
• Vela Diagnostics
• Roche Diagnostics
• AMOY Diagnostics CO. LTD.
• Quidel Corporation
• Bio SB
• Biocartis
• Exact Science

In August 2021, Myriad Genetics Inc. launched RiskScore that offers breast cancer assessment to improve patient outcomes and reduce healthcare disparities. The obtained results are a combination of genetic markers, patient history, biological and clinical variables, and ancestry-specific data. 

Order Now: https://www.reportsanddata.com/checkout-form/3707

For the purpose of this report, Reports and Data has segmented into the global cancer diagnostics based on test type, application, end-use, and region:

Test Type Outlook (Revenue, USD Billion; 2018-2028)

• Imaging
• Laboratory Test
• Genetic Test
• Biopsy
• Endoscopy
• Others

Application Outlook (Revenue, USD Billion; 2018-2028)

• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Lung Cancer
• Prostate Cancer
• Skin Cancer
• Blood Cancer
• Ovarian Cancer
• Others

End-Use Outlook (Revenue, USD Billion; 2018-2028)

• Hospitals & Clinics
• Diagnostic Centers
• Research Institutes
• Others

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Rest Of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of MEA

Browse Similar Reports by Diagnostics Industry

Ketones Market By Type (Ketone Salts, Ketone Oil, Ketone Esters, Raspberry Ketone), By Form (Liquid, Solid), By Distribution Channel (Direct, Indirect), Application (Food & Beverage, Supplements, Cosmetics & Personal Care), and By Region Forecast to 2028

Heparin Market By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin), By Route of Administration (Subcutaneous, Intravenous), By Application, By End-Use, and By Region, Forecast to 2028

HIV Diagnostics Market Size, Share, Trends, By Product (Consumables, Instruments, Software & Services), By Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification), By End-use, and By Region Forecast to 2028

Hepatitis Diagnostic Test Market Size

, Share & Trends Analysis Report, By Diagnostic Tests (Blood Tests {Liver Function Tests, Immunoassays & Nucleic Acid Tests}, Imaging Tests, Liver Biopsy), By End User (Hospitals, Clinics, Research Institutes, Diagnostic Laboratories, Others) And Region Forecasts To 2028

Primary Care POC Diagnostics Market Size, Share & Analysis, By Product (Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility Testing, Thyroid Testing, Hematology Testing, Lipid Testing, And Others), By End Use (Pharmacy And Retail Clinics, Physician Office, Urgent Care Clinics, And Others), And By Region Forecast To 2028

Oncology Companion Diagnostics Market Size, Share & Analysis, By Product & Service (Product, Service), By Technology (Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In-situ Hybridization, Others), By Disease Type (Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Melanoma, Leukemia, Others), By End-use (Hospitals, Pathology/Diagnostic Laboratory, Academic Medical Centers), And By Region, Forecast To 2028

Hematology Diagnostics Market Size, Share & Analysis, By Product Type (Instruments, Reagents, Consumables, Stains, Others), By Test Type (Full Blood Count Testing, Red Blood Cells Testing, White Blood Cells Testing, Hemoglobin Testing, Hematocrit And Platelets, Blood Glucose Testing, Renal Profiling, Vitamin B12 Deficiency Testing, Others), By End-Use (Hospitals & Clinics, Diagnostic Laboratories, Others), And By Region Forecast To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com   
Direct Line: +1-212-710-1370
E-mail: [email protected] 
LinkedIn | Twitter | Blogs 
Read full Press Release at : https://www.reportsanddata.com/press-release/global-cancer-diagnostics-market

SOURCE Reports And Data